article · 2015
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
Amit M. Oza, Adrian Cook, Jacobus Pfisterer, Andrew Embleton-Thirsk, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey
845 citationsThe Lancet OncologyDOI: https://doi.org/10.1016/s1470-2045(15)00086-8Open accessPDF reported by metadataFull text reported by metadata